US$ 26.30
glutathione metabolic pathway Disruption in metabolism and altered energy production in the liver and kidney after ischemic acute kidney injury in mice Glutathione Pathways
Description
The Food and Drug Administration approved a new Alzheimers drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities in people with the disease, the drugmaker said Tuesday

| 04.21.26 | 10 min read

10.1158/1538-7445.AM2018-1727 111

PMID: 18492956
